Publications by authors named "Lisset Hermida"

Claim this Profile
A
A nasal vaccine candidate based on S2 and N proteins from SARS-CoV-2 generates a broad antibody response systemically and in the lower respiratory tract.
Yadira Lobaina, Rong Chen, Dania Vazquez-Blomquist, Edith Suzarte, Miaohong Zhang, Lisset Hermida

Immunol Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obtaining HBV core protein VLPs carrying SARS-CoV-2 nucleocapsid conserved fragments as vaccine candidates.
Yadira Lobaina, Alexis Musacchio, Panchao Ai, Rong Chen, Edith Suzarte, Lisset Hermida

Virol J· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Nasal Vaccine Candidate, Containing Three Antigenic Regions from SARS-CoV-2, to Induce a Broader Response.
Yadira Lobaina, Rong Chen, Edith Suzarte, Panchao Ai, Alexis Musacchio, Lisset Hermida

Vaccines (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality.
Yadira Lobaina, Rong Chen, Edith Suzarte, Panchao Ai, Vivian Huerta, Lisset Hermida

Viruses· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant protein based on domain III and capsid regions of zika virus induces humoral and cellular immune response in immunocompetent BALB/c mice.
Iris Valdes, Lázaro Gil, Laura Lazo, Karem Cobas, Yaremis Romero, Lisset Hermida

Vaccine· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad humoral immunity generated in mice by a formulation composed of two antigens from the Delta variant of SARS-CoV-2.
Yadira Lobaina, Rong Chen, Edith Suzarte, Panchao Ai, Vivian Huerta, Lisset Hermida

Arch Virol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-Reactive Profile Against Two Conserved Coronavirus Antigens in Sera from SARS-CoV-2 Hybrid and Vaccinated Immune Donors.
Yadira Lobaina, Rong Chen, Panchao Ai, Liling Yang, Liz Alvarez-Lajonchere, Lisset Hermida

Viral Immunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
Iris Valdés, Laura Lazo, Lisset Hermida, Gerardo Guillén, Lázaro Gil

Front Immunol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A heterologous prime-boost strategy for immunization against Dengue virus combining the Tetra DIIIC subunit vaccine candidate with the TV005 live-attenuated tetravalent vaccine.
Iris Valdés, Alienys Izquierdo, Karem Cobas, Phuong Thao, Hoang Anh Duc, Lisset Hermida

J Gen Virol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aiming at the heart: the capsid protein of dengue virus as a vaccine candidate.
Laura Lazo, Iris Valdes, Gerardo Guillén, Lisset Hermida, Lázaro Gil

Expert Rev Vaccines· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dose-response study in mice of a tetravalent vaccine candidate composed of domain III-capsid proteins from dengue viruses.
Iris Valdés, Ernesto Marcos, Edith Suzarte, Yusleidi Pérez, Enma Brown, Lisset Hermida

Arch Virol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tetravalent formulation of domain III-capsid proteins recalls memory B- and T-cell responses induced in monkeys by an experimental dengue virus infection.
Lázaro Gil, Laura Lazo, Iris Valdés, Edith Suzarte, Phuong Yen, Lisset Hermida

Clin Transl Immunology· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and Monkeys.
Lázaro Gil, Karem Cobas, Laura Lazo, Ernesto Marcos, Laura Hernández, Lisset Hermida

J Immunol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dengue encephalitis-associated immunopathology in the mouse model: Implications for vaccine developers and antigens inducer of cellular immune response.
Ernesto Marcos, Laura Lazo, Lázaro Gil, Alienys Izquierdo, Edith Suzarte, Lisset Hermida

Immunol Lett· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative proteomic analysis of growth hormone secretagogue A233 treatment of murine macrophage cells J774A.2 indicates it has a role in antiviral innate response.
Rebeca Martínez, Teresa Núñez de Villavicencio-Díaz, Aniel Sánchez, Yassel Ramos, Jesús Noda Ferro, Lisset Hermida

Biochem Biophys Rep· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Could an experimental dengue virus infection fail to induce solid immunity against homologous viral challenge in non-human primates?
Iris Valdés, Lázaro Gil, Laura Lazo, Ernesto Marcos, Jorge Martín, Lisset Hermida

Arch Virol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys.
Edith Suzarte, Lázaro Gil, Iris Valdés, Ernesto Marcos, Laura Lazo, Lisset Hermida

Int Immunol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetravalent dengue DIIIC protein together with alum and ODN elicits a Th1 response and neutralizing antibodies in mice.
Roland Zuest, Iris Valdes, David Skibinski, Yufang Lin, Ying Xiu Toh, Lisset Hermida

Vaccine· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2.
Lázaro Gil, Ernesto Marcos, Alienys Izquierdo, Laura Lazo, Iris Valdés, Lisset Hermida

Immunol Cell Biol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice.
Alienys Izquierdo, Angélica García, Laura Lazo, Lázaro Gil, Ernesto Marcos, Lisset Hermida

Arch Virol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus.
Edith Suzarte, Ernesto Marcos, Lázaro Gil, Iris Valdés, Laura Lazo, Lisset Hermida

Arch Virol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
Roland Züst, Ying-Xiu Toh, Iris Valdés, Daniela Cerny, Julia Heinrich, Lisset Hermida

J Virol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capsid protein: evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys.
Lázaro Gil, Alienys Izquierdo, Laura Lazo, Iris Valdés, Peris Ambala, Lisset Hermida

Virology· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olive baboons: a non-human primate model for testing dengue virus type 2 replication.
Iris Valdés, Lázaro Gil, Jorge Castro, Damián Odoyo, Rikoi Hitler, Lisset Hermida

Int J Infect Dis· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus.
Ernesto Marcos, Lázaro Gil, Laura Lazo, Alienys Izquierdo, Enma Brown, Lisset Hermida

Arch Virol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis